List of Tables
Table 1. Global Uterotonic Agent Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Uterotonic Agent Market Value by Dosage Form (US$ Million), 2025 vs 2032
Table 3. Global Uterotonic Agent Market Value by Indication (US$ Million), 2025 vs 2032
Table 4. Global Uterotonic Agent Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Uterotonic Agent Market Competitive Situation by Manufacturers in 2025
Table 6. Global Uterotonic Agent Sales (K Dose) of Key Manufacturers (2021–2026)
Table 7. Global Uterotonic Agent Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Uterotonic Agent Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Uterotonic Agent Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Uterotonic Agent Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Uterotonic Agent, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Uterotonic Agent, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Uterotonic Agent, Product Types and Applications
Table 14. Global Key Manufacturers of Uterotonic Agent, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Uterotonic Agent Companies by Tier (Tier 1, Tier 2, Tier 3), based on Uterotonic Agent Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Uterotonic Agent Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Uterotonic Agent Sales by Region (K Dose), 2021–2026
Table 20. Global Uterotonic Agent Sales Market Share by Region (2021–2026)
Table 21. Global Uterotonic Agent Sales by Region (K Dose), 2027–2032
Table 22. Global Uterotonic Agent Sales Market Share by Region (2027–2032)
Table 23. Global Uterotonic Agent Revenue by Region (US$ Million), 2021–2026
Table 24. Global Uterotonic Agent Revenue Market Share by Region (2021–2026)
Table 25. Global Uterotonic Agent Revenue by Region (US$ Million), 2027–2032
Table 26. Global Uterotonic Agent Revenue Market Share by Region (2027–2032)
Table 27. North America Uterotonic Agent Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Uterotonic Agent Sales by Country (K Dose), 2021–2026
Table 29. North America Uterotonic Agent Sales by Country (K Dose), 2027–2032
Table 30. North America Uterotonic Agent Revenue by Country (US$ Million), 2021–2026
Table 31. North America Uterotonic Agent Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Uterotonic Agent Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Uterotonic Agent Sales by Country (K Dose), 2021–2026
Table 34. Europe Uterotonic Agent Sales by Country (K Dose), 2027–2032
Table 35. Europe Uterotonic Agent Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Uterotonic Agent Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Uterotonic Agent Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Uterotonic Agent Sales by Region (K Dose), 2021–2026
Table 39. Asia Pacific Uterotonic Agent Sales by Region (K Dose), 2027–2032
Table 40. Asia Pacific Uterotonic Agent Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Uterotonic Agent Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Uterotonic Agent Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Uterotonic Agent Sales by Country (K Dose), 2021–2026
Table 44. Latin America Uterotonic Agent Sales by Country (K Dose), 2027–2032
Table 45. Latin America Uterotonic Agent Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Uterotonic Agent Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Uterotonic Agent Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Uterotonic Agent Sales by Country (K Dose), 2021–2026
Table 49. Middle East and Africa Uterotonic Agent Sales by Country (K Dose), 2027–2032
Table 50. Middle East and Africa Uterotonic Agent Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Uterotonic Agent Revenue by Country (US$ Million), 2027–2032
Table 52. Global Uterotonic Agent Sales (K Dose) by Type (2021–2026)
Table 53. Global Uterotonic Agent Sales (K Dose) by Type (2027–2032)
Table 54. Global Uterotonic Agent Sales Market Share by Type (2021–2026)
Table 55. Global Uterotonic Agent Sales Market Share by Type (2027–2032)
Table 56. Global Uterotonic Agent Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Uterotonic Agent Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Uterotonic Agent Revenue Market Share by Type (2021–2026)
Table 59. Global Uterotonic Agent Revenue Market Share by Type (2027–2032)
Table 60. Global Uterotonic Agent Price (US$/Dose) by Type (2021–2026)
Table 61. Global Uterotonic Agent Price (US$/Dose) by Type (2027–2032)
Table 62. Global Uterotonic Agent Sales (K Dose) by Application (2021–2026)
Table 63. Global Uterotonic Agent Sales (K Dose) by Application (2027–2032)
Table 64. Global Uterotonic Agent Sales Market Share by Application (2021–2026)
Table 65. Global Uterotonic Agent Sales Market Share by Application (2027–2032)
Table 66. Global Uterotonic Agent Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Uterotonic Agent Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Uterotonic Agent Revenue Market Share by Application (2021–2026)
Table 69. Global Uterotonic Agent Revenue Market Share by Application (2027–2032)
Table 70. Global Uterotonic Agent Price (US$/Dose) by Application (2021–2026)
Table 71. Global Uterotonic Agent Price (US$/Dose) by Application (2027–2032)
Table 72. Pfizer Company Information
Table 73. Pfizer Description and Business Overview
Table 74. Pfizer Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 75. Pfizer Uterotonic Agent Product
Table 76. Pfizer Recent Developments/Updates
Table 77. Novartis Company Information
Table 78. Novartis Description and Business Overview
Table 79. Novartis Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 80. Novartis Uterotonic Agent Product
Table 81. Novartis Recent Developments/Updates
Table 82. Sandoz Company Information
Table 83. Sandoz Description and Business Overview
Table 84. Sandoz Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 85. Sandoz Uterotonic Agent Product
Table 86. Sandoz Recent Developments/Updates
Table 87. Sanofi Company Information
Table 88. Sanofi Description and Business Overview
Table 89. Sanofi Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 90. Sanofi Uterotonic Agent Product
Table 91. Sanofi Recent Developments/Updates
Table 92. Teva Pharmaceutical Industries Company Information
Table 93. Teva Pharmaceutical Industries Description and Business Overview
Table 94. Teva Pharmaceutical Industries Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 95. Teva Pharmaceutical Industries Uterotonic Agent Product
Table 96. Teva Pharmaceutical Industries Recent Developments/Updates
Table 97. Mylan Company Information
Table 98. Mylan Description and Business Overview
Table 99. Mylan Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 100. Mylan Uterotonic Agent Product
Table 101. Mylan Recent Developments/Updates
Table 102. Fresenius Kabi Company Information
Table 103. Fresenius Kabi Description and Business Overview
Table 104. Fresenius Kabi Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 105. Fresenius Kabi Uterotonic Agent Product
Table 106. Fresenius Kabi Recent Developments/Updates
Table 107. Hikma Pharmaceuticals Company Information
Table 108. Hikma Pharmaceuticals Description and Business Overview
Table 109. Hikma Pharmaceuticals Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 110. Hikma Pharmaceuticals Uterotonic Agent Product
Table 111. Hikma Pharmaceuticals Recent Developments/Updates
Table 112. Aspen Pharmacare Company Information
Table 113. Aspen Pharmacare Description and Business Overview
Table 114. Aspen Pharmacare Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 115. Aspen Pharmacare Uterotonic Agent Product
Table 116. Aspen Pharmacare Recent Developments/Updates
Table 117. Sun Pharmaceutical Industries Company Information
Table 118. Sun Pharmaceutical Industries Description and Business Overview
Table 119. Sun Pharmaceutical Industries Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 120. Sun Pharmaceutical Industries Uterotonic Agent Product
Table 121. Sun Pharmaceutical Industries Recent Developments/Updates
Table 122. Lupin Company Information
Table 123. Lupin Description and Business Overview
Table 124. Lupin Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 125. Lupin Uterotonic Agent Product
Table 126. Lupin Recent Developments/Updates
Table 127. Torrent Pharmaceuticals Company Information
Table 128. Torrent Pharmaceuticals Description and Business Overview
Table 129. Torrent Pharmaceuticals Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 130. Torrent Pharmaceuticals Uterotonic Agent Product
Table 131. Torrent Pharmaceuticals Recent Developments/Updates
Table 132. Aurobindo Pharma Company Information
Table 133. Aurobindo Pharma Description and Business Overview
Table 134. Aurobindo Pharma Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 135. Aurobindo Pharma Uterotonic Agent Product
Table 136. Aurobindo Pharma Recent Developments/Updates
Table 137. Zydus Lifesciences Company Information
Table 138. Zydus Lifesciences Description and Business Overview
Table 139. Zydus Lifesciences Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 140. Zydus Lifesciences Uterotonic Agent Product
Table 141. Zydus Lifesciences Recent Developments/Updates
Table 142. Cipla Company Information
Table 143. Cipla Description and Business Overview
Table 144. Cipla Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 145. Cipla Uterotonic Agent Product
Table 146. Cipla Recent Developments/Updates
Table 147. Glenmark Pharmaceuticals Company Information
Table 148. Glenmark Pharmaceuticals Description and Business Overview
Table 149. Glenmark Pharmaceuticals Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 150. Glenmark Pharmaceuticals Uterotonic Agent Product
Table 151. Glenmark Pharmaceuticals Recent Developments/Updates
Table 152. Dr. Reddy’s Laboratories Company Information
Table 153. Dr. Reddy’s Laboratories Description and Business Overview
Table 154. Dr. Reddy’s Laboratories Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 155. Dr. Reddy’s Laboratories Uterotonic Agent Product
Table 156. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 157. Abbott Company Information
Table 158. Abbott Description and Business Overview
Table 159. Abbott Uterotonic Agent Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 160. Abbott Uterotonic Agent Product
Table 161. Abbott Recent Developments/Updates
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Uterotonic Agent Distributors List
Table 165. Uterotonic Agent Customers List
Table 166. Uterotonic Agent Market Trends
Table 167. Uterotonic Agent Market Drivers
Table 168. Uterotonic Agent Market Challenges
Table 169. Uterotonic Agent Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
Table 173. Authors List of This Report
List of Figures
Figure 1. Product Picture of Uterotonic Agent
Figure 2. Global Uterotonic Agent Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Uterotonic Agent Market Share by Type: 2025 & 2032
Figure 4. Oxytocin & Analogues Product Picture
Figure 5. Prostaglandins Product Picture
Figure 6. Ergot Alkaloids Product Picture
Figure 7. Global Uterotonic Agent Market Value by Dosage Form (US$ Million), 2021–2032
Figure 8. Global Uterotonic Agent Market Share by Dosage Form: 2025 vs 2032
Figure 9. Injectable Product Picture
Figure 10. Oral Product Picture
Figure 11. Vaginal / Sublingual Product Picture
Figure 12. Global Uterotonic Agent Market Value by Indication (US$ Million), 2021–2032
Figure 13. Global Uterotonic Agent Market Share by Indication: 2025 vs 2032
Figure 14. Postpartum Hemorrhage Product Picture
Figure 15. Labor Induction Product Picture
Figure 16. Labor Augmentation Product Picture
Figure 17. Global Uterotonic Agent Market Value by Application (US$ Million), 2021–2032
Figure 18. Global Uterotonic Agent Market Share by Application: 2025 & 2032
Figure 19. Hospitals
Figure 20. Maternity Clinics
Figure 21. Public Health Programs
Figure 22. Aid & NGO Procurement
Figure 23. Global Uterotonic Agent Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Uterotonic Agent Market Size (US$ Million), 2021–2032
Figure 25. Global Uterotonic Agent Sales (K Dose), 2021–2032
Figure 26. Global Uterotonic Agent Average Price (US$/Dose), 2021–2032
Figure 27. Uterotonic Agent Report Years Considered
Figure 28. Uterotonic Agent Sales Share by Manufacturers in 2025
Figure 29. Global Uterotonic Agent Revenue Share by Manufacturers in 2025
Figure 30. Top 5 and Top 10 Global Uterotonic Agent Players: Market Share by Revenue in Uterotonic Agent in 2025
Figure 31. Uterotonic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 32. Global Uterotonic Agent Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 33. North America Uterotonic Agent Sales Market Share by Country (2021–2032)
Figure 34. North America Uterotonic Agent Revenue Market Share by Country (2021–2032)
Figure 35. United States Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Canada Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Europe Uterotonic Agent Sales Market Share by Country (2021–2032)
Figure 38. Europe Uterotonic Agent Revenue Market Share by Country (2021–2032)
Figure 39. Germany Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. France Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. U.K. Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Italy Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Russia Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Asia Pacific Uterotonic Agent Sales Market Share by Region (2021–2032)
Figure 45. Asia Pacific Uterotonic Agent Revenue Market Share by Region (2021–2032)
Figure 46. China Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Japan Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. South Korea Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. India Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Australia Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. China Taiwan Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Southeast Asia Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Uterotonic Agent Sales Market Share by Country (2021–2032)
Figure 54. Latin America Uterotonic Agent Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Uterotonic Agent Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Uterotonic Agent Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. UAE Uterotonic Agent Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Uterotonic Agent by Type (2021–2032)
Figure 64. Global Revenue Market Share of Uterotonic Agent by Type (2021–2032)
Figure 65. Global Uterotonic Agent Price (US$/Dose) by Type (2021–2032)
Figure 66. Global Sales Market Share of Uterotonic Agent by Application (2021–2032)
Figure 67. Global Revenue Market Share of Uterotonic Agent by Application (2021–2032)
Figure 68. Global Uterotonic Agent Price (US$/Dose) by Application (2021–2032)
Figure 69. Uterotonic Agent Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
